192 related articles for article (PubMed ID: 11274418)
1. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.
Lai JP; Ho WZ; Zhan GX; Yi Y; Collman RG; Douglas SD
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3970-5. PubMed ID: 11274418
[TBL] [Abstract][Full Text] [Related]
2. A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes.
Lai JP; Ho WZ; Yang JH; Wang X; Song L; Douglas SD
J Neuroimmunol; 2002 Jul; 128(1-2):101-8. PubMed ID: 12098517
[TBL] [Abstract][Full Text] [Related]
3. Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.
Guo CJ; Li Y; Tian S; Wang X; Douglas SD; Ho WZ
J Investig Med; 2002 Nov; 50(6):435-42. PubMed ID: 12425430
[TBL] [Abstract][Full Text] [Related]
4. Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes.
Wang X; Douglas SD; Metzger DS; Guo CJ; Li Y; O'Brien CP; Song L; Davis-Vogal A; Ho WZ
Alcohol Clin Exp Res; 2002 Dec; 26(12):1880-6. PubMed ID: 12500113
[TBL] [Abstract][Full Text] [Related]
5. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
[TBL] [Abstract][Full Text] [Related]
6. Substance P enhances HIV-1 replication in latently infected human immune cells.
Li Y; Douglas SD; Song L; Sun S; Ho WZ
J Neuroimmunol; 2001 Dec; 121(1-2):67-75. PubMed ID: 11730941
[TBL] [Abstract][Full Text] [Related]
7. Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage.
Borrajo A; Ranazzi A; Pollicita M; Bellocchi MC; Salpini R; Mauro MV; Ceccherini-Silberstein F; Perno CF; Svicher V; Aquaro S
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234437
[No Abstract] [Full Text] [Related]
8. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
[TBL] [Abstract][Full Text] [Related]
10. Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro.
Wang X; Douglas SD; Lai JP; Tuluc F; Tebas P; Ho WZ
J Neuroimmune Pharmacol; 2007 Mar; 2(1):42-8. PubMed ID: 18040825
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
[TBL] [Abstract][Full Text] [Related]
12. L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes.
Ho WZ; Starr SE; Sison A; Douglas SD
Clin Diagn Lab Immunol; 1997 May; 4(3):352-7. PubMed ID: 9144376
[TBL] [Abstract][Full Text] [Related]
13. Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.
Ho WZ; Zhu XH; Song L; Lee HR; Cutilli JR; Douglas SD
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):451-9. PubMed ID: 7632461
[TBL] [Abstract][Full Text] [Related]
14. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages.
Kedzierska K; Maerz A; Warby T; Jaworowski A; Chan H; Mak J; Sonza S; Lopez A; Crowe S
AIDS; 2000 Aug; 14(12):1739-48. PubMed ID: 10985310
[TBL] [Abstract][Full Text] [Related]
16. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
17. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1.
Baba M; Miyake H; Okamoto M; Iizawa Y; Okonogi K
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):935-41. PubMed ID: 10890354
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes.
Lane BR; Strieter RM; Coffey MJ; Markovitz DM
J Virol; 2001 Jul; 75(13):5812-22. PubMed ID: 11390582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
